Patent Assignment
Reel/Frame 067663/0413
Change of Name
Recorded: 2024-06-06
Pages: 18
Assignor
ERYDEL S.P.A.
Executed: 2024-01-18
Assignee
QUINCE THERAPEUTICS S.P.A.
VIA A. MEUCCI, 3, BRESSO, 20091, ITALY
Covered Property
(1)
Engineering New Metabolic Pathways in Isolated Cells for the Degradation of Guanidinoacetic Acid and Simultaneous Production of Creatine
Application:
18/563,750 →
Publication:
US 2025/0340852
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 6, 2024
From: ROSSI, LUIGIA; MAMBRINI, GIOVANNI; ALIANO, MATTIA PAOLO; BIANCHI, MARZIA
To: ERYDEL S.P.A.
Reel/Frame 067663/0365 →
Assignment of Assignor's Interest
Jan 5, 2026
From: QUINCE THERAPEUTICS S.P.A.
To: QUINCE THERAPEUTICS, INC.
Reel/Frame 074201/0923 →
Assignment of Assignor's Interest
Jun 17, 2026
From: QUINCE THERAPEUTICS, INC.
To: AYMA THERAPEUTICS INC.
Reel/Frame 075892/0192 →